NYMC > News and Events > NYMC in the News

Cardiac output monitoring device receives FDA clearance

December 17, 2018

BioInc“A key challenge in realizing the potential clinical benefits of [cardiac output] monitoring is that many monitors fail to track [cardiac output] changes accurately when fluid and vasoactive drug therapy are administered,” said Marc Zemel, SM, MBA, co-founder and CEO of Retia Medical

BioInc news: Marc Zemel, SM, MBA, co-founder and CEO of Retia Medical, a BioInc client

Source: Healio